Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Metadata

Item Type:	Article
Authors/Creators:	Oza, AM Cook, AD Pfisterer, J Embleton, A Ledermann, JA Pujade-Lauraine, E Kristensen, G Carey, MS Beale, P Cervantes, A Park-Simon, T-W Rustin, G Joly, F Mirza, MR Plante, M Quinn, M Poveda, A Jayson, GC Stark, D https://orcid.org/0000-0002-6172-733X Swart, AM Farrelly, L Kaplan, R Parmar, MKB Perren, TJ https://orcid.org/0000-0001-8472-8856
Copyright, Publisher and Additional Information:	© Oza et al. Open Access article distributed under the terms of CC BY http://creativecommons.org/licenses/by/3.0/
Dates:	Published: August 2015 Published (online): 23 June 2015 Accepted: 1 May 2015
Institution:	The University of Leeds
Depositing User:	Symplectic Publications
Date Deposited:	03 Mar 2016 14:23
Last Modified:	11 Apr 2018 15:51
Published Version:	http://dx.doi.org/10.1016/S1470-2045(15)00086-8
Status:	Published
Publisher:	Elsevier
Identification Number:	10.1016/S1470-2045(15)00086-8
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:95006

Download

Published Version

Filename: Oza Lancet onc 2015.pdf

Licence: CC-BY 3.0

CLICK TO DOWNLOAD

[thumbnail of Oza Lancet onc 2015.pdf]

CORE (COnnecting REpositories)

CORE (COnnecting REpositories)